Showing results (281-290 of 296) with videos related to

Sort By:
Pageof 30
Drug Discovery Today|February 22, 2025
Unlocking disease insights to facilitate drug development: Pharmaceutical industry-academia collaborations in inflammation and immunologyElena Peeva, Emma Guttman-Yassky, Yuji Yamaguchi, et al.
Explore (New York, N.Y.)|November 13, 2012
Patients seek integrative medicine for preventive approach to optimize healthRuth Q Wolever, Donald I Abrams, Benjamin Kligler, et al.
The British Journal of Dermatology|June 6, 2023
Once-daily roflumilast foam 0.3% for scalp and body psoriasis: a randomized, double-blind, vehicle-controlled phase IIb studyLeon H Kircik, Javier Alonso-Llamazares, Neal Bhatia, et al.
Dermatology and Therapy|May 9, 2024
Triple Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% for Acne: Efficacy and Safety from a Pooled Phase 3 AnalysisLeon H Kircik, Linda Stein Gold, Michael Gold, et al.
Journal of the American Academy of Dermatology|January 22, 2024
Roflumilast foam 0.3% for adolescent and adult patients with seborrheic dermatitis: A randomized, double-blinded, vehicle-controlled, phase 3 trialAndrew Blauvelt, Zoe D Draelos, Linda Stein Gold, et al.
The Journal of Pediatrics|November 11, 2006
Exchange blood transfusion compared with simple transfusion for first overt stroke is associated with a lower risk of subsequent stroke: a retrospective cohort study of 137 children with sickle cell anemiaMonica L Hulbert, Douglas J Scothorn, Julie A Panepinto, et al.
NPJ Breast Cancer|January 31, 2024
Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi techniqueEmily J Gallagher, Heather Moore, Mario E Lacouture, et al.
The Journal of Pediatrics|April 16, 2002
Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial strokeDouglas J Scothorn, Cynthia Price, Daniel Schwartz, et al.
JAMA|September 20, 2022
Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical TrialsMark G Lebwohl, Leon H Kircik, Angela Y Moore, et al.
JAMA|March 3, 2011
Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trialMark T Gladwin, Gregory J Kato, Debra Weiner, et al.
Pageof 30